Category: compounding
TGA accepts AndroFeme 1 for evaluation in postmenopausal women with Hypoactive Sexual Desire Dysfunction.
Posted: December 5, 2019
TGA accepts AndroFeme 1 for evaluation in postmenopausal women with HSDD. Perth, Western Australia; Dec. 05, 2019 — Lawley Pharmaceuticals today announced AndroFeme 1,… Continue Reading →
Gender disparity in sexual health options for women: Experts call on pharma and drug regulators to address
Posted: August 9, 2019
In 2015 Comment in the prestigious medical journal Lancet Diabetes & Endocrinology by two of the world’s leading female sexual health specialists, Prof…. Continue Reading →
Categories: menopause, compounding
Menopause specialists warn against dangers of “bioidentical hormones”
Posted: July 17, 2019
On Monday 15th July 2019 in a comprehensive interview on the Life Matters program (ABC Radio National) two of Australia’s premier menopause specialists, Dr Elizabeth Farrell and… Continue Reading →
Categories: testosterone, compounding
Federal Court Proceedings Demonstrate Risk To Compounding Pharmacies
Posted: August 10, 2017
MEDIA RELEASE 3rd August 2017 A recent Federal Court case highlights the very real risk and cost to Compounding Pharmacies who do not… Continue Reading →